AGIO (STOCKS)
Agios Pharmaceuticals, Inc.
$33.555000
-0.655000 (-1.91%)
Prev close: $34.210000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Brian M. Goff
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,144.33M
- Employees
- 488
- P/E (TTM)
- -4.88
- P/B (TTM)
- 1.99
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
7
Buy
4
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-1.69 | $-1.70 | +0.0113 | +0.66% |
|
Mar 2026 (Q1)
|
$-1.69 | $-1.84 | +0.1467 | +7.99% |
|
Dec 2025 (Q4)
|
$-1.86 | $-1.99 | +0.1252 | +6.31% |
|
Sep 2025 (Q3)
|
$-1.78 | $-1.94 | +0.1567 | +8.09% |
Financial Statements
| Revenues | $98.34M |
| Benefits Costs and Expenses | $531.40M |
| Cost Of Revenue | $7.87M |
| Costs And Expenses | $557.36M |
| Gross Profit | $90.47M |
| Operating Expenses | $549.49M |
| Selling, General, and Administrative Expenses | $192.74M |
| Research and Development | $356.75M |
| Operating Income/Loss | -$459.02M |
| Income/Loss From Continuing Operations After Tax | -$411.29M |
| Income/Loss From Continuing Operations Before Tax | -$433.07M |
| Net Income/Loss | -$411.29M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$411.29M |
| Net Income/Loss Available To Common Stockholders, Basic | -$411.29M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$7.01 |
| Diluted Earnings Per Share | -$7.01 |
| Basic Average Shares | 117,402,616 |
| Diluted Average Shares | 117,402,616 |
| Assets | $1.11B |
| Current Assets | $717.67M |
| Cash | $1.00B |
| Inventory | $35.75M |
| Noncurrent Assets | $390.76M |
| Fixed Assets | $9.95M |
| Other Non-current Assets | $380.81M |
| Liabilities | $82.40M |
| Current Liabilities | $70.22M |
| Accounts Payable | $16.35M |
| Wages | $14.75M |
| Other Current Liabilities | $39.12M |
| Noncurrent Liabilities | $12.19M |
| Equity | $1.03B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.03B |
| Liabilities And Equity | $1.11B |
| Net Cash Flow From Operating Activities | -$360.60M |
| Net Cash Flow From Operating Activities, Continuing | -$360.60M |
| Net Cash Flow From Investing Activities | $367.15M |
| Net Cash Flow From Investing Activities, Continuing | $367.15M |
| Net Cash Flow From Financing Activities | $12.22M |
| Net Cash Flow From Financing Activities, Continuing | $12.22M |
| Net Cash Flow | $18.78M |
| Net Cash Flow, Continuing | $18.78M |
| Comprehensive Income/Loss | -$413.74M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$413.74M |
| Other Comprehensive Income/Loss | -$413.74M |